J Med Microbiol NEW Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Defontaine, A.
Right arrow Articles by Hallet, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Defontaine, A.
Right arrow Articles by Hallet, J. N.
Agricola
Right arrow Articles by Defontaine, A.
Right arrow Articles by Hallet, J. N.

The Journal of Medical Microbiology, Vol 48, Issue 7 663-670, Copyright © 1999 by Society for General Microbiology


JOURNAL ARTICLE

In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata

A. Defontaine, J. P. Bouchara, P. Declerk, C. Planchenault, D. Chabasse and J. N. Hallet
Laboratoire de Biotechnologie, UPRES 2161 Biocatalyse, Nantes, France. defontaine@nat.sut.sciences.univ-nantes.Fr

A commercially available disk diffusion procedure was used in a large-scale study to evaluate the susceptibility of a wide range of Candida isolates to polyenes and azoles. With almost all isolates of C. glabrata resistant colonies were present within the inhibition zones for the azole compounds fluconazole, ketoconazole and miconazole, and less frequently for isoconazole, econazole and clotrimazole. Ten randomly selected isolates were cloned by limiting dilution and the susceptibility of the resulting strains to polyenes and azoles was determined. All strains presented a similar susceptibility pattern with sensitivity to polyenes and the presence of resistant colonies for all azole compounds except tioconazole. For each strain and each antifungal agent, one of these resistant colonies was subcultured and studied for antifungal susceptibility. All these colonies showed similar properties regardless of which antifungal agent allowed their selection, with increased sensitivity to polyenes and cross-resistance to the azole compounds except tioconazole. Similar results were obtained on Shadomy's modified medium and on synthetic medium. Likewise, determination of MICs by the Etest method confirmed the resistance to fluconazole. Comparative growth studies revealed a respiratory deficiency in the mutants caused by mitochondrial DNA (mtDNA) deletions. In addition, 'petite' mutants were obtained from a wild-type strain by exposure to ethidium bromide, and these respiratory mutants were shown to be resistant to azoles. These results demonstrate the relationship between mtDNA deficiency and resistance to azoles, and provide an interesting model to study the mechanisms of action of these antifungal agents.


This article has been cited by other articles:


Home page
MicrobiologyHome page
B. G. Oliver, P. M. Silver, C. Marie, S. J. Hoot, S. E. Leyde, and T. C. White
Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi
Microbiology, March 1, 2008; 154(3): 960 - 970.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Cheng, C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen
A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1855 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Vandeputte, G. Tronchin, T. Berges, C. Hennequin, D. Chabasse, and J.-P. Bouchara
Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth
Antimicrob. Agents Chemother., March 1, 2007; 51(3): 982 - 990.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H.-F. Tsai, A. A. Krol, K. E. Sarti, and J. E. Bennett
Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1384 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. J. Helmerhorst, C. Venuleo, D. Sanglard, and F. G. Oppenheim
Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5
Antimicrob. Agents Chemother., March 1, 2006; 50(3): 1100 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Vandeputte, G. Larcher, T. Berges, G. Renier, D. Chabasse, and J.-P. Bouchara
Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4608 - 4615.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. Brun, F. Dalle, P. Saulnier, G. Renier, A. Bonnin, D. Chabasse, and J.-P. Bouchara
Biological consequences of petite mutations in Candida glabrata
J. Antimicrob. Chemother., August 1, 2005; 56(2): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Borst, M. T. Raimer, D. W. Warnock, C. J. Morrison, and B. A. Arthington-Skaggs
Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 783 - 787.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J.-P. Vermitsky and T. D. Edlind
Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor
Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3773 - 3781.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Kaur, I. Castano, and B. P. Cormack
Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria
Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1600 - 1613.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Brun, T. Berges, P. Poupard, C. Vauzelle-Moreau, G. Renier, D. Chabasse, and J.-P. Bouchara
Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata
Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1788 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Brun, C. Aubry, O. Lima, R. Filmon, T. Berges, D. Chabasse, and J.-P. Bouchara
Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata
Antimicrob. Agents Chemother., March 1, 2003; 47(3): 847 - 853.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Sanglard, F. Ischer, and J. Bille
Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata
Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1174 - 1183.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
D. P. Kontoyiannis and G. S. May
{{delta}}-Aminolaevulinic acid modulates the resistance to fluconazole in a hem1 mutant of Saccharomyces cerevisiae
J. Antimicrob. Chemother., December 1, 2000; 46(6): 1044 - 1046.
[Full Text] [PDF]


Home page
J Med MicrobiolHome page
J.-P. BOUCHARA, R. ZOUHAIR, S. LE BOUDOUIL, G. RENIER, R. FILMON, D. CHABASSE, J.-N. HALLET, and A. DEFONTAINE
In-vivo selection of an azole-resistant petite mutant of Candida glabrata
J. Med. Microbiol., November 1, 2000; 49(11): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. P. Kontoyiannis
Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae
J. Antimicrob. Chemother., August 1, 2000; 46(2): 191 - 197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1999 Society for General Microbiology.